The decrease in breast-cancer incidence in 2003 in the United States.
By P. Ravdin, Kathleen A. Cronin, N. Howlader, C. Berg, R. Chlebowski, E. Feuer, B. Edwards, D. Berry. New England Journal of Medicine, 2007
988 citations recorded by the source corpus.
Subfields: Cancer Research, Oncology
View Paper: https://www.semanticscholar.org/paper/3c3b0172897c64c4d2dc9d71c5bc44e1ba2dd8d9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Oncology
- A. Jemal
- R. Siegel
- C. DeSantis
- Jiemin Ma
- Elizabeth E. Ward
- S. Fedewa
- Ann Goding Sauer
- Robert A. Smith
Citations in the corpus
- Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. (2009, neutral): “7% decrease from the previous year (12).”
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels (2013, background): “org Although overall breast cancer incidence rates stabilized during the most recent time period (2005–2009) after sharply decreasing between 2002 and 2003 because of reductions in the use of postmenopausal hormone replacement therapy (63,64), during the period from 2000 to 2009 incidence rates incr”
- Risk Factors and Preventions of Breast Cancer (2017, background): “The recurrence rate is also high among breast cancer survivors who take HRT, and the HR for a new breast tumor is 3.6 [77].”
- Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy (2011, positive): “The observed decline in breast cancer incidence rates in the United States and many other countries after 2002 that followed reductions in the prevalence of hormonal therapy use (21,22) provides independent support for the epidemiological data.”
- Triple Negative Breast Cancer Cell Lines: One Tool in the Search for Better Treatment of Triple Negative Breast Cancer (2010, background): “The continuing decrease in mortality from breast cancer has been attributed to early detection due to screening, improved adjuvant therapy, and more recently to decreases in the incidence due to lowered rates of usage of hormone replacement therapy [3, 4].”